Michael D. West
Direttore/Membro del Consiglio presso Cell Cure Neurosciences Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Robert W. Peabody | M | 69 |
Cell Cure Neurosciences Ltd.
 Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | - |
| David Schlachet | M | 78 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | - |
| Rami Skaliter | M | 66 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | 7 anni |
| Benjamin Reubinoff | M | - |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | 18 anni |
| Raf Hofstein | M | 75 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | - |
| Adi Mohanty | M | 57 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | - |
| Francine Del Ricci | F | - |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Michael West | M | 71 |
Andrews University
Baylor College of Medicine
Rensselaer Polytechnic Institute
| 10 anni |
| Edward J. Arcuri | M | 73 |
Rensselaer Polytechnic Institute
| 4 anni |
| Alfred Kingsley | M | 81 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | 13 anni |
| Paul Roughan | M | - |
Rensselaer Polytechnic Institute
| 6 anni |
| Thomas N. Iovino | M | - |
Rensselaer Polytechnic Institute
| 5 anni |
| David H. Boguslawski | M | 69 |
Rensselaer Polytechnic Institute
| 5 anni |
| Steven Levy | M | 68 |
Rensselaer Polytechnic Institute
| 6 anni |
| Gary DiElsi | M | 66 |
Rensselaer Polytechnic Institute
| 5 anni |
| Jordan Fraser Posner | M | - |
Rensselaer Polytechnic Institute
| 5 anni |
| Steve Z. Szczepanski | M | - |
Rensselaer Polytechnic Institute
| 5 anni |
| Bill Jerome | M | 72 |
Rensselaer Polytechnic Institute
| 5 anni |
| Daniel George Hennessy | M | 65 |
Rensselaer Polytechnic Institute
| 6 anni |
| Tony DiMarco | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| William Edelman | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| B. Jayant Baliga | M | - |
Rensselaer Polytechnic Institute
| 3 anni |
| William M. Stout | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Joseph E. Coffey | M | - |
Rensselaer Polytechnic Institute
| 1 anni |
| Kenneth R. Adamo | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| William F. Schwitter | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Matthew Schulman | M | 67 |
Rensselaer Polytechnic Institute
| 4 anni |
| Douglas M. Gage | M | 67 |
Rensselaer Polytechnic Institute
| 4 anni |
| Fred Blum | M | 71 |
Rensselaer Polytechnic Institute
| 4 anni |
| Philip Meier | M | 65 |
Rensselaer Polytechnic Institute
| 4 anni |
| Stan Bernard | M | - |
Baylor College of Medicine
| 4 anni |
| Martin G. Travers | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Mark A. Miller | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Mituo Hirota | M | 79 |
Rensselaer Polytechnic Institute
| 1 anni |
| Greg Vas Nunes | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Moshe Hukaylo | M | - |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | - |
| Robert Philip Rotella | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| James Bedford Downing | M | 70 |
Rensselaer Polytechnic Institute
| 4 anni |
| Edison Mawikere | M | - |
Andrews University
| 2 anni |
| Mike Stamatedes | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Vincent White | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Ronald R. Papa | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Mike Gausling | M | 66 |
Rensselaer Polytechnic Institute
| 4 anni |
| Dennis T. Scurletis | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Barry Borak | M | - |
Rensselaer Polytechnic Institute
| 2 anni |
| Stephen A. Belden | M | 68 |
Rensselaer Polytechnic Institute
| 4 anni |
| Thomas H. Strang | M | 73 |
Rensselaer Polytechnic Institute
| 2 anni |
| Michael S. White | M | 65 |
Rensselaer Polytechnic Institute
| 4 anni |
| Larry G. Schultz | M | 74 |
Rensselaer Polytechnic Institute
| 2 anni |
| Janice DuFour | F | 66 |
Rensselaer Polytechnic Institute
| 4 anni |
| John F. Hennessy | M | 68 |
Rensselaer Polytechnic Institute
| 4 anni |
| Gary DiCamillo | M | 73 |
Rensselaer Polytechnic Institute
| 4 anni |
| William J. Merritt | M | 65 |
Rensselaer Polytechnic Institute
| 4 anni |
| John Seitz | M | 72 |
Rensselaer Polytechnic Institute
| 1 anni |
| Nancy T. Chang | M | 74 |
Baylor College of Medicine
| 5 anni |
| Mark Edward Donovan | M | 65 |
Rensselaer Polytechnic Institute
| 4 anni |
| Thomas N. Clancy | M | 66 |
Rensselaer Polytechnic Institute
| 4 anni |
| Mark A. McKinlay | M | - |
Rensselaer Polytechnic Institute
| 3 anni |
| Steven Plust | M | 65 |
Rensselaer Polytechnic Institute
| 4 anni |
| Cyril Medunã | M | 66 |
Rensselaer Polytechnic Institute
| 4 anni |
| Amit Srivastava | M | - |
Rensselaer Polytechnic Institute
| 2 anni |
| Julie Shimer | M | 71 |
Rensselaer Polytechnic Institute
| 4 anni |
| Christopher J. Reed | M | 66 |
Rensselaer Polytechnic Institute
| 4 anni |
| James Barber | M | 70 |
Rensselaer Polytechnic Institute
| 4 anni |
| Amanda Thorneycroft | F | - |
Andrews University
| 4 anni |
| John D. Bennett | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Frederick P. Keller | M | - |
Rensselaer Polytechnic Institute
| 5 anni |
| M. Eric Krisl | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Cynthia A. Ambres | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Steven J. Walerstein | M | - |
Rensselaer Polytechnic Institute
| 4 anni |
| Jackson Tai | M | 73 |
Rensselaer Polytechnic Institute
| 4 anni |
| William Cohn | M | 64 |
Baylor College of Medicine
| 3 anni |
| Tim Stout | M | - |
Baylor College of Medicine
| 7 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 64 | 87.67% |
| Israele | 9 | 12.33% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Michael D. West
- Contatti personali
